Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

Mamta Kumari, Amitabha Acharya and Praveen Thaggikuppe Krishnamurthy
Beilstein J. Nanotechnol. 2023, 14, 912–926. https://doi.org/10.3762/bjnano.14.75

Cite the Following Article

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
Mamta Kumari, Amitabha Acharya and Praveen Thaggikuppe Krishnamurthy
Beilstein J. Nanotechnol. 2023, 14, 912–926. https://doi.org/10.3762/bjnano.14.75

How to Cite

Kumari, M.; Acharya, A.; Krishnamurthy, P. T. Beilstein J. Nanotechnol. 2023, 14, 912–926. doi:10.3762/bjnano.14.75

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Presentation Graphic

Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG Size: 10.4 MB Download

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Parvin, N.; Mandal, T. K.; Joo, S.-W. The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems. Pharmaceutics 2024, 16, 1366. doi:10.3390/pharmaceutics16111366
  • Rodponthukwaji, K.; Thongchot, S.; Deureh, S.; Thongkleang, T.; Thaweesuvannasak, M.; Srichan, K.; Srisawat, C.; Thuwajit, P.; Nguyen, K. T.; Tadpetch, K.; Thuwajit, C.; Punnakitikashem, P. Development of cancer-associated fibroblasts-targeting polymeric nanoparticles loaded with 8-O-methylfusarubin for breast cancer treatment. International journal of pharmaceutics: X 2024, 8, 100294. doi:10.1016/j.ijpx.2024.100294
  • Velásquez, F.; Frazao, M.; Diez, A.; Villegas, F.; Álvarez-Bidwell, M.; Rivas-Pardo, J. A.; Vallejos-Vidal, E.; Reyes-López, F.; Toro-Ascuy, D.; Ahumada, M.; Reyes-Cerpa, S. Salmon-IgM Functionalized-PLGA Nanosystem for Florfenicol Delivery as an Antimicrobial Strategy against Piscirickettsia salmonis. Nanomaterials (Basel, Switzerland) 2024, 14, 1658. doi:10.3390/nano14201658
  • Cong, X.; Zhang, Z.; Li, H.; Yang, Y.-G.; Zhang, Y.; Sun, T. Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium. Journal of nanobiotechnology 2024, 22, 620. doi:10.1186/s12951-024-02892-9
  • Maskur; Wongso, H.; Humani, T. S.; Effendi, N.; Palangka, C. R.; Pujiyanto, A.; Setiawan, H.; Juliyanto, S.; Ridwan, M.; Ritawidya, R. Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies. Journal of Drug Delivery Science and Technology 2024, 100, 106104. doi:10.1016/j.jddst.2024.106104
  • Jain, M.; Yu, X.; Schneck, J. P.; Green, J. J. Nanoparticle Targeting Strategies for Lipid and Polymer‐Based Gene Delivery to Immune Cells In Vivo. Small Science 2024. doi:10.1002/smsc.202400248
  • Marques, A. C.; Costa, P. C.; Velho, S.; Amaral, M. H. Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles. Life (Basel, Switzerland) 2024, 14, 489. doi:10.3390/life14040489
  • Singh, M. T.; Thaggikuppe Krishnamurthy, P.; Magham, S. V. Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells. Journal of drug targeting 2024, 32, 258–269. doi:10.1080/1061186x.2024.2309568
  • Lim, S. H.; Yee, G. T.; Khang, D. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier. International journal of nanomedicine 2024, 19, 2529–2552. doi:10.2147/ijn.s450853
  • Ashour, M. M.; Mabrouk, M.; Aboelnasr, M. A.; Beherei, H. H.; Tohamy, K. M.; Das, D. B. Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges. Pharmaceutics 2023, 15, 2635. doi:10.3390/pharmaceutics15112635
Other Beilstein-Institut Open Science Activities